Ngm Biopharmaceuticals Inc (NGM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 56,923 | N/A | N/A | N/A |
| Marketable Securities | 149,710 | N/A | N/A | N/A |
| Receivables | 3,669 | N/A | N/A | N/A |
| TOTAL | $214,557 | $N/A | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 23,893 | N/A | N/A | N/A |
| Other Non-Current Assets | 7,635 | 0 | 0 | 0 |
| TOTAL | $31,528 | $N/A | $N/A | $N/A |
| Total Assets | $246,085 | $N/A | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 5,775 | 0 | 0 | 0 |
| Accrued Expenses | 14,003 | N/A | N/A | N/A |
| Other current liabilities | 2,683 | N/A | N/A | N/A |
| TOTAL | $41,486 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Deferred Revenues | 19,025 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 308,852 | 0 | 0 | 0 |
| TOTAL | $312,794 | $N/A | $N/A | $N/A |
| Total Liabilities | $354,280 | $N/A | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 7 | N/A | N/A | N/A |
| Retained earnings | -147,193 | N/A | N/A | N/A |
| Other shareholders' equity | -267 | 0 | 0 | 0 |
| TOTAL | $-108,195 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $246,085 | $0 | $0 | $0 |